
Metropolis Healthcare reported a 23 percent year-on-year rise in consolidated net sales to Rs 424.7 crore for Q4 FY26, with net profit increasing 74 percent to Rs 51 crore. EBITDA grew 68 percent to Rs 116.18 crore. Sequentially, revenue and profit also showed growth. For FY26, consolidated revenue rose 24 percent to Rs 1,645.8 crore, and net profit increased 31 percent to Rs 191.2 crore. Earnings per share stood at Rs 9.19 for FY26, reflecting operational expansion and acquisitions.
The articles focus on financial performance without political framing, presenting corporate results and operational details. Both sources emphasize growth metrics and acquisitions, reflecting a business-centric perspective without political commentary or partisan viewpoints.
Coverage across the articles is predominantly positive, highlighting significant increases in revenue, profit, and operational expansion. While some cost increases are noted, the overall tone underscores strong financial performance and growth momentum.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| moneycontrol | Metropolis Consolidated March 2026 Net Sales at Rs 424.68 crore, up 22.99 Y-o-Y- Moneycontrol.com | Center | Positive |
| freepressjournal | Metropolis Healthcare Q4 Profit Jumps 74 To 51 Crore, Revenue Climbs 23 | Center | Positive |
freepressjournal broke this story on 13 May, 01:50 pm. Other outlets followed.
Well-covered story — coverage matches public importance.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.